Parametrica Management Ltd Sells 4,339 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Parametrica Management Ltd cut its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 31.4% during the fourth quarter, HoldingsChannel reports. The fund owned 9,500 shares of the biopharmaceutical company’s stock after selling 4,339 shares during the quarter. Alnylam Pharmaceuticals comprises approximately 4.6% of Parametrica Management Ltd’s holdings, making the stock its 8th biggest […]

Related Keywords

Phillip Zamore ,David Bartel ,Pushkal Garg ,Thomas Tuschl ,Invesco Ltd ,Alnylam Pharmaceuticals ,Alnylam Pharmaceuticals Inc ,Alnylam Pharmaceuticals Trading ,Nasdaq ,Canaccord Genuity Group ,Parametrica Management Ltd ,Asset Management Americas Inc ,Jpmorgan Chase Co ,Nuveen Asset Management ,Quarter For Alnylam Pharmaceuticals ,News Ratings For Alnylam Pharmaceuticals Daily ,Vanguard Group Inc ,Get Rating ,Management Ltd ,Asset Management ,Street Corp ,Management Americas ,Lall Franchini ,Genuity Group ,Noble Laureate ,Visit Holdingschannel ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,